NASDAQ: IMUX
Immunic Inc Stock Ownership - Who owns Immunic?

Insider buying vs selling

Have Immunic Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Duane NashExecutive Chairman2025-06-1320,000$0.84
$16.70kBuy
Jason TardioPresident and COO2025-06-0512,512$0.79
$9.88kBuy
Joerg NeermannDirector2025-06-0530,000$0.76
$22.80kBuy
Daniel VittCEO and Director2025-06-0415,000$0.77
$11.55kBuy
Joerg NeermannDirector2025-06-0470,000$0.77
$53.90kBuy
Glenn WhaleyChief Financial Officer2025-06-0345,000$0.71
$32.09kBuy
Richard Alan RudickDirector2025-06-03143,075$0.70
$100.01kBuy
Glenn WhaleyChief Financial Officer2025-05-3025,000$0.56
$14.00kBuy
Richard Alan RudickDirector2024-11-1287,300$1.15
$100.39kBuy

1 of 1

IMUX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IMUX insiders and whales buy or sell their stock.

IMUX Shareholders

What type of owners hold Immunic Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bvf Inc9.29%8,902,972$6.84MInstitution
Soleus Capital Management LP7.61%7,293,007$5.60MInstitution
Muneer A. Satter7.44%7,132,277$5.48MInsider
Avidity Partners Management LP4.65%4,454,408$3.42MInstitution
Vanguard Group Inc4.10%3,931,548$3.02MInstitution
Focus Partners Wealth2.70%2,583,457$1.98MInstitution
V. Cooperatieve Ua Lsp2.26%2,162,782$1.66MInsider
Omega Fund Management LLC1.87%1,788,160$1.37MInstitution
Adage Capital Partners GP LLC1.46%1,398,600$1.07MInstitution
Fund Nv1.43%1,371,494$1.05MInsider

1 of 3

IMUX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IMUX42.22%16.57%Net BuyingNet Buying
INO30.46%69.54%Net SellingNet Selling
BMEA55.29%44.71%Net Buying
PYXS48.83%37.69%Net Buying
IGMS29.64%54.27%Net SellingNet Selling

Immunic Stock Ownership FAQ

Who owns Immunic?

Immunic (NASDAQ: IMUX) is owned by 42.22% institutional shareholders, 16.57% Immunic insiders, and 41.21% retail investors. Muneer A. Satter is the largest individual Immunic shareholder, owning 7.13M shares representing 7.44% of the company. Muneer A. Satter's Immunic shares are currently valued at $5.32M.

If you're new to stock investing, here's how to buy Immunic stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.